Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Iolyx Therapeutics is a biotechnology research and healthcare service provider for ocular diseases.
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.
Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
Lassen Therapeutics develops antibody biotherapeutics to help improve the lives of patients suffering from serious diseases.
Rocket Pharmaceuticals is a biotech company that develops a pipeline of genetic therapies for rare childhood disorders.
Radionetics Oncology is a pharmaceutical company that focuses on the discovery and development of novel radiotherapeutics.
Krystal Biotech provide significant clinical benefit for patients suffering from rare debilitating disorders..
Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.
Dascena develops machine learning algorithms to enable early disease intervention and improve care outcomes for patients.
SanReno Therapeutics develop, manufacture and commercialize kidney disease therapies.
Entasis Therapeutics is developing a portfolio of innovative cures.
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Zavante focuses on developing novel therapies to improve the outcomes of hospitalized patients.
Inipharm is a biopharmaceutical company.
Lengo Therapeutics a biopharmaceutical company focused on the discovery and development of cancer treatments.
Alcresta develops enzyme-based nutritional products for infants and adults with acute and chronic diseases.
Recida Therapeutics is a Biotechnology company.
Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.
Non-nucleotide, conditional modulators of the STING pathway to treat cancer and infectious disease.
Outpost Medicine is a biopharmaceutical company
Silvergate Pharmaceuticals develops and commercializes pediatric medications.
Calibrium is an emerging privately held biopharmaceutical company.
Frazier Healthcare Partners has invested in 50 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Frazier Healthcare Partners's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Medical, Therapeutics. The firm invests across 15 different industry categories.
Among tracked funding rounds, Rocket Pharmaceuticals received $175.0M in a Post Ipo Equity round. Frazier Healthcare Partners's total known invested capital is $2.8B.
Frazier Healthcare Partners's average investment size is $64.7M across its portfolio of 50 companies.
Recent Frazier Healthcare Partners portfolio additions include Iolyx Therapeutics, Scilex Holding Company, Semnur Pharmaceuticals, Iterum Therapeutics, Tarsus Pharmaceuticals. These companies were founded in 2020 or later.